Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions

Hematologic NeoplasmsBurns

Interventions

DEVICE

Hypoxic Red Blood Cells

Hypoxic Red Blood Cells manufactured with the Hemanext ONE device- CPD/PAGGSM Red Blood Cells, Leukocytes Reduced, and O2/CO2 Reduced

Trial Locations (1)

Haukeland University Hospital, Bergen